GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Clinical trial NCT01245764 · COMPLETED
Trial details
- NCT number
- NCT01245764
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-21
- Primary completion
- 2013-04-15
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.